Pharmaceutical intermediate production belongs to high-precision and high-cleanliness chemical production, which has extremely strict requirements on the purity, sterility, and impurity content of nitrogen. Nitrogen is widely used in the nitrogen protection, material transfer, reaction oxygen isolation, and finished product sealing links of pharmaceutical intermediate synthesis. Impurities, bacteria, and moisture in nitrogen will directly affect the purity and quality of pharmaceutical intermediates, and even cause product scrapping. Therefore, the special sterile nitrogen generator system for pharmaceutical intermediate production adopts a multi-stage purification and sterile treatment process, which fully meets the GMP production standards of the pharmaceutical industry and provides ultra-clean and sterile nitrogen for pharmaceutical production.

The sterile nitrogen system for pharmaceutical intermediates consists of an oil-free sterile air supply system, high-purity PSA nitrogen generation host, multi-stage sterile purification module, ultra-drying system, and constant-temperature sterile gas storage tank. The front-end air supply system adopts a medical-grade oil-free air compressor, which completely avoids oil pollution of the air source. Through primary filtration, medium-efficiency filtration, and high-efficiency sterile filtration, it removes dust, particles, and microorganisms in the air source from the source. The nitrogen generation host adopts high-purity carbon molecular sieve with low impurity precipitation, and the internal pipeline is made of 304 stainless steel to avoid rust and pollution, ensuring that the initial nitrogen purity reaches more than 99.9%.

The core module of the system is the multi-stage sterile purification and sterilization unit, which is specially customized for pharmaceutical production scenarios. It is equipped with high-temperature sterilization filters, activated carbon decontamination layers, and molecular sieve deep drying modules, which can effectively remove trace water, residual oxygen, organic impurities, and microbial bacteria in nitrogen. After multi-stage purification, the nitrogen has zero bacterial content, ultra-low moisture and residual impurity content, fully meeting the sterile and dust-free production requirements of pharmaceutical intermediates. The system is also equipped with a constant-temperature gas storage tank to avoid nitrogen temperature fluctuation affecting the chemical reaction stability of pharmaceutical intermediates, ensuring the consistency of product quality.

In terms of system control and management, the equipment adopts an intelligent full-automatic control system, which can real-timely monitor nitrogen purity, sterility, humidity, pressure, and other core parameters, and automatically record operating data to meet the data traceability requirements of pharmaceutical GMP certification. The equipment has a self-purification and self-detection function, which can regularly complete pipeline self-cleaning and sterile detection to prevent bacterial growth in the gas circuit. All components of the system meet pharmaceutical-grade cleanliness standards, with no dead corners in the pipeline and easy cleaning and disinfection, which can stably provide continuous sterile high-purity nitrogen for the synthesis, purification, and storage of pharmaceutical intermediates, and effectively improve the yield and quality of pharmaceutical products.